179 related articles for article (PubMed ID: 23686841)
1. Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques.
Brown CA; Karimi MK; Tian L; Flores H; Su Y; Tabbal SD; Loftin SK; Moerlein SM; Perlmutter JS
Ann Neurol; 2013 Oct; 74(4):602-10. PubMed ID: 23686841
[TBL] [Abstract][Full Text] [Related]
2. Validation of nigrostriatal positron emission tomography measures: critical limits.
Karimi M; Tian L; Brown CA; Flores HP; Loftin SK; Videen TO; Moerlein SM; Perlmutter JS
Ann Neurol; 2013 Mar; 73(3):390-6. PubMed ID: 23423933
[TBL] [Abstract][Full Text] [Related]
3. Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaques.
Shimony JS; Rutlin J; Karimi M; Tian L; Snyder AZ; Loftin SK; Norris SA; Perlmutter JS
PLoS One; 2018; 13(9):e0202201. PubMed ID: 30183721
[TBL] [Abstract][Full Text] [Related]
4. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys.
Brown CA; Campbell MC; Karimi M; Tabbal SD; Loftin SK; Tian LL; Moerlein SM; Perlmutter JS
Exp Neurol; 2012 Jul; 236(1):190-7. PubMed ID: 22579525
[TBL] [Abstract][Full Text] [Related]
5. In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.
Tian L; Karimi M; Brown CA; Loftin SK; Perlmutter JS
Brain Res; 2014 Jul; 1571():49-60. PubMed ID: 24845719
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model.
Tian L; Xia Y; Flores HP; Campbell MC; Moerlein SM; Perlmutter JS
PLoS One; 2015; 10(7):e0132064. PubMed ID: 26135399
[TBL] [Abstract][Full Text] [Related]
7. Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.
Dugan LL; Tian L; Quick KL; Hardt JI; Karimi M; Brown C; Loftin S; Flores H; Moerlein SM; Polich J; Tabbal SD; Mink JW; Perlmutter JS
Ann Neurol; 2014 Sep; 76(3):393-402. PubMed ID: 25043598
[TBL] [Abstract][Full Text] [Related]
8. (18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism.
Masilamoni G; Votaw J; Howell L; Villalba RM; Goodman M; Voll RJ; Stehouwer J; Wichmann T; Smith Y
Exp Neurol; 2010 Dec; 226(2):265-73. PubMed ID: 20832405
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.
Masilamoni GJ; Bogenpohl JW; Alagille D; Delevich K; Tamagnan G; Votaw JR; Wichmann T; Smith Y
Brain; 2011 Jul; 134(Pt 7):2057-73. PubMed ID: 21705423
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.
Chao KT; Tsao HH; Weng YH; Hsiao IT; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lin KJ
Synapse; 2012 Sep; 66(9):823-31. PubMed ID: 22623146
[TBL] [Abstract][Full Text] [Related]
11. Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices.
Pate BD; Kawamata T; Yamada T; McGeer EG; Hewitt KA; Snow BJ; Ruth TJ; Calne DB
Ann Neurol; 1993 Sep; 34(3):331-8. PubMed ID: 8363350
[TBL] [Abstract][Full Text] [Related]
12. Parkinson׳s disease-related modulation of functional connectivity associated with the striatum in the resting state in a nonhuman primate model.
Li J; Luo C; Chen Y; Chen Q; Huang R; Sun J; Gong Q; Wu X; Qi Z; Liang Z; Li L; Li H; Li P; Wang W; Shang HF
Brain Res; 2014 Mar; 1555():10-9. PubMed ID: 24530271
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP
PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461
[TBL] [Abstract][Full Text] [Related]
14. PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133).
Toomey JS; Bhatia S; Moon LT; Orchard EA; Tainter KH; Lokitz SJ; Terry T; Mathis JM; Penman AD
PLoS One; 2012; 7(6):e39041. PubMed ID: 22723923
[TBL] [Abstract][Full Text] [Related]
15. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous partial recovery of striatal dopaminergic uptake despite nigral cell loss in asymptomatic MPTP-lesioned female minipigs.
Lillethorup TP; Noer O; Alstrup AKO; Real CC; Stokholm K; Thomsen MB; Zaer H; Orlowski D; Mikkelsen TW; Glud AN; Nielsen EHT; Schacht AC; Winterdahl M; Brooks DJ; Sørensen JCH; Landau AM
Neurotoxicology; 2022 Jul; 91():166-176. PubMed ID: 35569565
[TBL] [Abstract][Full Text] [Related]
17. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
[TBL] [Abstract][Full Text] [Related]
18. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of
Sanchez-Catasus CA; Bohnen NI; Yeh FC; D'Cruz N; Kanel P; Müller MLTM
J Nucl Med; 2021 Apr; 62(4):545-552. PubMed ID: 32859707
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
Kozina EA; Khakimova GR; Khaindrava VG; Kucheryanu VG; Vorobyeva NE; Krasnov AN; Georgieva SG; Kerkerian-Le Goff L; Ugrumov MV
J Neurol Sci; 2014 May; 340(1-2):198-207. PubMed ID: 24768159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
